Telescope Innovations Corp
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Henry Dubina
- Full Time Employees
- 22
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- 301 - 2386 East Mall Vancouver BC Canada V6T 1Z3
- IPO Date
- Sep 27, 2021
- Website
- telescopeinnovations.com
- Similar Companies
- Business
- Telescope Innovations Corp is a chemical technology company specializing in the development and commercialization of advanced process innovation and automation solutions for the pharmaceutical, chemical, and battery material industries. The company’s core products include flexible robotic platforms, artificial intelligence software for experimental optimization, and advanced process analytical tools such as the DirectInject-LC™, a hardware and software ecosystem enabling online chemistry sampling and analysis with integration to industry-standard chromatography data systems. Additionally, Telescope Innovations develops proprietary chemical manufacturing processes, including the ReCRFT™ recrystallization refinement technology for lithium processing and the DualPure™ technology for producing battery-grade lithium sulfide. These technologies serve pharmaceutical research and manufacturing and critical battery materials supply chains, particularly lithium refinement and recycling. Founded in 2017 and headquartered in Vancouver, Canada, Telescope Innovations markets its products and technologies primarily in North America, with recent global distribution agreements expanding reach. Notable recent developments include a multi-year funded collaboration with Pfizer focused on developing self-driving laboratories that integrate robotics and AI to accelerate pharmaceutical R&D; a global distribution agreement with METTLER TOLEDO for the DirectInject-LC™ product; and securing conditional government funding of up to CAD 3.36 million to advance lithium processing technology scale-up and deployment. The company also commenced pilot-scale lithium refinement and shipped first samples of battery-grade lithium sulfide produced by its DualPure™ process to leading battery manufacturers in Asia and North America. Telescope Innovations has pursued strategic advancements in AI-guided optimization, automation, and sustainable battery material manufacturing to drive growth and innovation across its industry segments. These operational advances have supported continued financial growth, with revenues reaching CAD 4.4 million for fiscal year 2024, representing a 57% increase over the previous year. Telescope Innovations actively invests in R&D and commercialization capacity, reinforcing its position as a cutting-edge provider of chemical process automation and advanced manufacturing solutions for pharmaceuticals, chemicals, and critical battery materials.
Company News
Telescope Innovations to Attend the 2026 Planet Microcap Investment Conference in Toronto
Telescope Innovations to Participate in the Canadian Delegation to BIOPLUS-INTERPHEX Korea (BIX) 2026
Telescope Innovations to Attend the 2026 Cantech Investment Conference in Toronto
Telescope Innovations Reports 60% Revenue Growth in Preliminary Unaudited Fiscal Year 2026 Results
Telescope Innovations CTO Prof. Jason Hein to Attend Invitation-Only NSF Programmable Cloud Laboratories Kickoff in Washington, DC
Telescope Announces Appointment of Dr. E. Neil Lewis to the Board of Directors
Telescope Announces Changes to its Board of Directors
Telescope Innovations to Attend Fastmarkets Global Lithium, Battery & Critical Materials in Las Vegas
Telescope Innovations Provides Financial Results of Third Fiscal Quarter 2026
Telescope Innovations to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award
Telescope Innovations Secures Third Self-Driving Lab Deployment with Major Global Pharmaceutical Company
Telescope Innovations Shares Spring 2026 Conference and Events Lineup
Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026
Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation
Telescope Innovations and AGI SDA Launch Technology Development Collaboration
Telescope Strengthens Investor Communications Strategy
VIDEO - BTV Visits Atlas Salt, Graphene Manufacturing, Telescope Innovations, Nevada Organic Phosphate, Maple Gold, Intrepid Metals and Nine Mile Metals
Telescope Innovations Installs Second Self-Driving Lab at Pfizer
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026